modified the transferrin receptor of blood-derived exosomes with magnetic nanoparticles and subsequently utilized external magnets to direct the exosomes to mouse tumors, thereby creating targeted drug delivery vehicles for cancer therapy. Here, TFRC is linked to cancer.